PM&R,
Journal Year:
2023,
Volume and Issue:
16(6), P. 605 - 625
Published: Oct. 31, 2023
Persistent
chest
pain
(PCP)
following
acute
COVID-19
infection
is
a
commonly
reported
symptom
with
an
unclear
etiology,
making
its
management
challenging.
This
scoping
review
aims
to
address
the
knowledge
gap
surrounding
characteristics
of
PCP
COVID-19,
causes,
and
potential
treatments.
64
studies,
including
observational
(prospective,
retrospective,
cross-sectional,
case
series,
case-control)
one
quasi-experimental
study,
from
databases
Embase,
PubMed/MEDLINE,
Cochrane
CENTRAL,
Google
Scholar,
Database
Systematic
Reviews,
Scopus.
Studies
on
patients
mild,
moderate,
severe
were
included.
any
age,
that
persisted
disease,
irrespective
etiology
or
duration
A
total
35
studies
symptoms
(0.24%-76.6%)
at
average
follow-up
3
months
longer,
12
1-3
17
less
than
1-month
not
specified.
was
common
mild-severe
infection,
mostly
reported.
Fourteen
proposed
etiologies
endothelial
dysfunction,
cardiac
ischemia,
vasospasm,
myocarditis,
arrhythmia,
pneumonia,
pulmonary
embolism,
postural
tachycardia
syndrome,
noted
MRI
(cMRI)
changes.
Evaluation
methods
included
cardiopulmonary
tests,
as
well
tests
such
flow-mediated
dilatation,
cMRI,
single-photon
emission
computed
tomography
myocardial
perfusion
imaging,
exercise
testing.
Only
study
specific
treatment
(sulodexide).
prevalent
various
etiologies.
Further
research
needed
establish
better
understanding
causes
develop
targeted
treatments
for
COVID-19.
Frontiers in Rehabilitation Sciences,
Journal Year:
2024,
Volume and Issue:
5
Published: July 12, 2024
Introduction
Long
COVID
involves
debilitating
symptoms,
many
of
which
mirror
those
observed
with
dysautonomia,
and
care
must
be
taken
rehabilitation
for
autonomic
dysfunction
to
avoid
post-exertional
malaise/post-exertional
symptom
exacerbation.
Resonant
breathing
(breathing
slowly
at
a
defined
rate
breaths
per
minute)
requires
less
exertion
can
potentially
improve
function.
The
objective
this
work
was
report
on
the
impact
resonant
program
self-reported
symptoms
wellbeing
in
people
COVID.
Methods
A
retrospective
analysis
de-identified
data
completed
convenience
sample
COVID,
who
participated
Meo
Health
(formerly
known
as
Stasis
HP)
program.
Participants
baseline
follow
up
surveys.
Results
Data
were
available
99
participants.
Most
measures
improved
up,
largest
differences
participant
seen
sense
wellness
(47.3%,
p
<
0.0001),
ability
focus
(57.5%,
breathe
(47.5%,
control
stress
(61.8%,
0.0001)
sleep
quality
(34.9%,
=
0.0002).
(92%)
participants
reported
improvement
Patient
Global
Impression
Change
Scale.
Conclusion
Self-reported
completing
breathing.
considered
an
option
within
broader
treatment
plan
European Journal of Neurology,
Journal Year:
2024,
Volume and Issue:
31(10)
Published: Aug. 1, 2024
In
October
2020,
the
European
Academy
of
Neurology
(EAN)
consensus
statement
for
management
patients
with
neurological
diseases
during
coronavirus
disease
2019
(COVID-19)
pandemic
was
published.
Due
to
important
changes
and
developments
that
have
happened
since
then,
need
has
arisen
critically
reassess
original
recommendations
address
new
challenges.
Long
COVID,
also
known
as
Post-Acute
Sequelae
of
SARS-CoV-2
Infection
(PASC),
is
a
complex,
multisystem
illness
with
poorly
understood
pathophysiology,
absence
specific
diagnostic
tests
or
criteria,
evidence-based
treatments.
With
over
200
identified
symptoms
and
approximately
10%
COVID-19
cases
resulting
in
PASC,
it
challenge
to
provide
comprehensive
treatment
at
scale
commensurate
the
burden.
The
diverse
manifestations
encompassing
numerous
medical
specialties,
typically
place
primary
care
providers
(PCPs)
forefront
management,
navigating
an
evolving
landscape
research
lack
guidelines.
This
paper
presents
pragmatic,
structured
framework
for
PASC
management
care,
integrating
current
knowledge
best
practices.
approach
individualized,
addressing
PASC's
broad
symptomatology
through
four-step
framework.
first
step
focuses
on
energy
strategies,
emphasizing
prevention
post-exertional
malaise,
cardinal
feature
PASC.
second
step,
intentional
rehabilitation,
employs
carefully
titrated
multidisciplinary
modalities
address
physical,
cognitive,
emotional
domains.
third
utilizes
symptomatic
both
pharmacological
non-pharmacological
interventions,
targeting
debilitating
like
fatigue,
insomnia,
chronic
pain.
fourth
outlines
trialing
experimental,
targeted
therapies
that
may
impact
underlying
pathophysiology.
These
treatments,
while
experimental
lacking
quality
evidence
be
available
off-label
individual
basis
following
thorough
risk-benefit
discussion.
stepwise
can
equip
PCPs
effectively
most
common
disabling
individualize
remain
attuned
scientific
understanding
condition.
This
chapter
covers
how
COVID-19
infection
can
affect
the
mental
health
of
children
and
teens
at
different
ages.
It
begins
by
describing
lives
four
people
ages
who
are
affected
COVID-19.
They
are:
Audra
–
an
18-month-old
girl
was
cared
for
her
grandmother;
Emiliano
a
9-year-old
boy
with
asthma;
Raven
autistic
12-year-old
chose
their
own
name;
Maeve
17-year-old
young
woman.
Due
to
impact
on
brain,
bring
wide
range
neuropsychiatric
conditions
first
time.
As
other
forms
sadness,
sadness
that
occurs
may
respond
non-pharmacological
treatments
and,
times,
also
medications.
There
no
data
link
beginning
new
substance
use
disorders
in
teens.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 27, 2023
Abstract
COVID-19
has
resulted
in
over
645
million
hospitalization
and
7
deaths
globally.
However,
many
questions
still
remain
about
clinical
complications
if
these
changed
with
different
circulating
SARS-CoV-2
strains.
We
analyzed
a
2.5-year
retrospective
cohort
of
47,063
encounters
for
21,312
acute
care
patients
at
five
Central
Texas
hospitals
define
distinct
trajectory
groups
(TGs)
latent
class
mixed
modeling,
based
on
the
World
Health
Organization
Ordinal
Scale.
Using
this
TG
framework,
we
evaluated
association
demographics,
diagnoses,
vitals,
labs,
imaging,
consultations,
medications
severity
broad
outcomes.
Patients
within
6
TGs
differed
manifestations
multi-organ
disease
multiple
factors.
The
proportion
mild
increased
time,
particularly
during
Omicron
waves.
Age
separated
fatal
patients,
though
did
not
distinguish
severe
versus
critical
disease.
Male
Hispanic/Latino
demographics
were
associated
more
severe/critical
TGs.
More
had
higher
rate
neuropsychiatric
brain
which
change
significantly
across
variant
severely
affected
also
demonstrated
an
immunological
signature
high
neutrophils
immature
granulocytes,
low
lymphocytes
monocytes.
Interestingly,
albumin
was
one
best
lab
predictors
malnutrition
raising
concern
nutritional
insufficiency
influencing
Despite
this,
only
small
fraction
labs
checked
(pre-albumin,
thiamine,
Vitamin
D,
B
vitamins)
or
received
targeted
interventions
to
address
deficiencies
such
as
vitamin
replacement.
Our
findings
underscore
significant
link
between
severity,
complications,
key
risk
factors
outcomes
raise
question
need
widespread
early
assessment
patients’
neurological,
psychiatric,
status
settings
help
identify
those
PM&R,
Journal Year:
2023,
Volume and Issue:
16(6), P. 605 - 625
Published: Oct. 31, 2023
Persistent
chest
pain
(PCP)
following
acute
COVID-19
infection
is
a
commonly
reported
symptom
with
an
unclear
etiology,
making
its
management
challenging.
This
scoping
review
aims
to
address
the
knowledge
gap
surrounding
characteristics
of
PCP
COVID-19,
causes,
and
potential
treatments.
64
studies,
including
observational
(prospective,
retrospective,
cross-sectional,
case
series,
case-control)
one
quasi-experimental
study,
from
databases
Embase,
PubMed/MEDLINE,
Cochrane
CENTRAL,
Google
Scholar,
Database
Systematic
Reviews,
Scopus.
Studies
on
patients
mild,
moderate,
severe
were
included.
any
age,
that
persisted
disease,
irrespective
etiology
or
duration
A
total
35
studies
symptoms
(0.24%-76.6%)
at
average
follow-up
3
months
longer,
12
1-3
17
less
than
1-month
not
specified.
was
common
mild-severe
infection,
mostly
reported.
Fourteen
proposed
etiologies
endothelial
dysfunction,
cardiac
ischemia,
vasospasm,
myocarditis,
arrhythmia,
pneumonia,
pulmonary
embolism,
postural
tachycardia
syndrome,
noted
MRI
(cMRI)
changes.
Evaluation
methods
included
cardiopulmonary
tests,
as
well
tests
such
flow-mediated
dilatation,
cMRI,
single-photon
emission
computed
tomography
myocardial
perfusion
imaging,
exercise
testing.
Only
study
specific
treatment
(sulodexide).
prevalent
various
etiologies.
Further
research
needed
establish
better
understanding
causes
develop
targeted
treatments
for
COVID-19.